Express Scripts, CVS Face ERISA Suit Over EpiPen Costs

By Dani Kass (June 5, 2017, 6:16 PM EDT) -- Express Scripts, CVS Health and Prime Therapeutics on Friday were drawn into the conflict over how EpiPens became so expensive after a potential class of patients accused the pharmacy benefit managers of violating the Employee Retirement Income Security Act by putting their own interests before those of patients....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!